🇺🇸 FDA
Pipeline program

EXPAREL and Bupivacaine

402-C-413

Approved small_molecule terminated

Quick answer

EXPAREL and Bupivacaine for Postoperative Pain Management is a Approved program (small_molecule) at Pacira BioSciences with 1 ClinicalTrials.gov record(s).

Program details

Company
Pacira BioSciences
Indication
Postoperative Pain Management
Phase
Approved
Modality
small_molecule
Status
terminated

Clinical trials